Prostate-specific antigen, Gleason sum and clinical T stage for predicting the need for radionuclide bone scan for prostate cancer patients in Japan

International Journal of Urology

Volumn 12, Issue 8, 2005, Pages 728-732

  Ishizuka, Osamu ^a   Tanabe, Tomoaki ^a   Nakayama, Tsuyoshi ^a   Kawakami, Masako ^a   Kinebuchi, Yoshiaki ^a   Nishizawa, Osamu ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Prostate cancer; Prostate specific antigen; Radionuclide bone scan

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER STAGING; CONTROLLED STUDY; ECHOGRAPHY; GLEASON SCORE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BONE NEOPLASMS; HUMANS; JAPAN; LINEAR MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 28544432684     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2005.01118.x     Document Type: Article

References (9)

1. Middleton RG, Thompson IM, Austenfeld MS et al. Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. J. Urol. 1995; 154: 2144-8.
2. Baker LH, Hanks G, Gersherson D et al. NCCN Prostate cancer guidelines. The national comprehensive cancer network. Oncology 1996; 10 (Suppl.): 265-88.
3. Richie JP, Murphy GP, Walther P. Prostate cancer surgical practice guidelines. Society of surgical oncology practice guidelines. Oncology (Huntingt) 1997; 11: 907-12.
4. O'Dowd GJ, Veltri RW, Orozco R, Miller MC, Oesterling JE. Update on the appropriate staging evaluation for newly diagnosed prostate cancer. J. Urol 1997; 158 (3 Pt 1): 687-98.
5. Coffy DS. Similarities of prostate and breast cancer, evolution, diet, and estrogens. Urology 2001; 57 (Suppl.): 31-8.
6. Presti JRJC, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J. Urol 2000; 163: 163-7.
7. Chybowski FM, Keller JJ, Bergstralh EJ, Oesterling JE. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. J. Urol 1991; 145: 313-18.
8. Pantelides ML, Bowman SP, George JR. Levels of prostate specific antigen that predict skeletal spread in prostate cancer. Br. J. Urol. 1992; 70: 299-303.
9. Kosuda S, Yoshimura I, Aizawa T et al. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? Cancer 2002; 94: 964-72.